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Background/introduction
Recently, first studies on MRgFUS for therapy of loca-
lized prostate cancer have been presented. However,
MRI is not only useful to monitor and guide FUS pros-
tate cancer therapy but might add valuable morphologic
and functional information for therapy stratification and
outcome. Since multi-parametric MR protocols are
time-consuming to generate and evaluate, they are not
performed during an MRgFUS session.
Rather these data are acquired before MRgFUS for ther-
apy planning and after therapy for outcome assessment.
This approach leads to a plethora of MR images (before,
during and after therapy) that can be difficult to analyze
and correlate. To support the radiologist, a software proto-
type was therefore developed to analyze MRgFUS therapy
outcome based on image registration and synchronization.
Methods
Initially, the workflow of MRgFUS in combination with
multi-parametric MR examinations before and after
therapy was analyzed. Based on the analysis, a software
prototype addressing the specific workflow was built
with the development environment MeVisLab. The soft-
ware comprises the following functionalities: 2D viewers
with basic interaction functionality (zoom, window/level
modification, overlays), display of FUS temperature
maps (Fig 1), image ordering and classification, auto-
matic image registration, interactive registration refine-
ment, synchronization cursor, contouring tool for
segmentation and annotations, and ROI statistics. To
analyze therapy outcome all available MR data of the
patient are imported. Data are automatically ordered
and classified for automatic post-processing and
visualization. Next, images from different examinations
are automatically co-registered. The linear registration
focusses on T2w MR images which are available in
every examination. If results are insufficient, registration
can be manually refined. The user then selects images
for correlated display which are synchronized with
crosshairs.
Additionally, ROIs can be placed and tracked on fol-
low-up images or across modalities to better discrimi-
nate between tumor recurrence and scar formation in
suspicious areas. MR thermometry temperature maps
can be imported as well to correlate the applied ther-
mal dose with post-therapeutic image changes.
Furthermore, contrast-enhanced images acquired at
the end of a therapy session can be compared with
diagnostic or follow-up images to check if all affected
areas were covered.
Results and conclusions
A stable version of the software was released for clini-
cal testing. First tests were performed on anonymized
data of prostate cancer patients who had extensive MR
imaging prior to and past cryo therapy (Fig 2), as well
as on meat data treated with FUS. The software imple-
ments all necessary features for analyzing the therapy
outcome and correlation with previous diagnostic and
therapeutic data. In addition it could be used for ther-
apy planning. Further evaluation of the software,
including a registration accuracy evaluation, is cur-
rently in preparation.
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Figure 1 T1w MR image of a meat sample with temperature map overlay.
Figure 2 Screenshot of the software called Local Therapy Control showing pre-therapeutic (top row) and post-therapeutic (bottom row)
prostate T2w and ADC images and a tracked ROI. Images are synchronized at the cross-hair position based on a registration.
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